Develops and manufactures technology-driven, difficult-to-develop specialty generic oral solids and liquids for the U.S. market, managing R&D through FDA approval to commercial production. Operates with in-house scientific development and partners with other pharmaceutical firms to combine development, manufacturing, and marketing capabilities.